Development of polymeric nanopaclitaxel and comparison with free paclitaxel for effects on cell proliferation of MCF-7 and B16F0 carcinoma cells

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 5, 2014, Pages 2335-2340

  Yadav, Deepak ^a   Anwar, Mohammad Faiyaz ^b   Garg, Veena ^c   Kardam, Hemant ^d   Beg, Mohd Nadeem ^a   Suri, Suruchi ^e   Gaur, Sikha ^f   Asif, Mohd ^a  

^a Faculty of Medicine   (India)

^b Department of Chemistry ^*  (India)

^c BANASTHALI UNIVERSITY   (India)

^d Department of Geography   (India)

^e HAMDARD UNIVERSITY   (India)

^f PDM College of Pharmacy   (India)

Author keywords

B16F0; Cancer cell lines MCF 7; NIPAAm VP nanoparticles; Paclitaxel; Sustain drug delivery

Indexed keywords

ACRYLAMIDE DERIVATIVE; ANTINEOPLASTIC AGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER; N-ISOPROPYLACRYLAMIDE; NANOPARTICLE; PACLITAXEL; POLYMER;

BREAST NEOPLASMS; CARCINOMA; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; HUMAN; MCF 7 CELL LINE; MELANOMA, EXPERIMENTAL; PARTICLE SIZE; PHARMACOLOGY; TUMOR CELL LINE;

ACRYLAMIDES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HUMANS; MCF-7 CELLS; MELANOMA, EXPERIMENTAL; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYMERS;

EID: 84899117824     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.5.2335     Document Type: Article

References (35)

1. Bartoli MH, Boitard M, Fessi H, et al (1990). In vitro and in vivo antitumoral activity of free and encapsulated Taxol. J Microencapsul, 7, 191-7.
2. Chen DB, Yang TZ, Lu WL, Zhang Q (2001). In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing Paclitaxel. Chem Pharm Bull, 49, 1444-7.
3. Crosasso P, Ceruti M, Brusa P, et al (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Rel, 63, 19-30.
4. Deng C, Jiang Y, Cheng R, Meng F, Zhong Z (2012). Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: Promises, progress and prospects. Nano Today, 7, 467-480.
5. Dhar S, Kolishetti N, Lippard SJ, Farokhzad OC (2011). Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci U S A, 108, 1850-5.
6. Fonseca C, Simoes S, Gaspar R (2002). Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Rel, 83, 273-86.
7. Goldspiel BR (1997). Clinical overview of the taxanes. Pharmacothe, 17, 110-25.
8. Gurses N, Topcul M (2013). The effect of abraxane on cell kinetic parameters of HeLa cells. Asian Pac J Cancer Prev, 14, 4229-33.
9. Hamidi M, Azadi A, Rafiei P (2008). Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev, 60, 1638-49.
10. Jabbari E, Yang X, Moeinzadeh S, He X (2013). Drug release kinetics, cell uptake, and tumor toxicity of hybrid VVVVVVKK peptide-assembled polylactide nanoparticles. Eur J Pharm Biopharm, 84, 49-62.
11. Jeong B, Bae YH, Kim SW (1999). Thermoreversible gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions. Macromol, 32, 7064-9.
12. Kataoka K, Harada A, Nagasaki Y (2001). Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev, 47, 113-31.
13. Kikuchi A, Okano T (1998). Biorelated Polymers and Gels. Academic Press, Boston, MA, 1-28.
14. Kwon GS, Okano T (1996). Polymeric micelles as new drug carriers. Adv Drug Deliv Rev, 21, 107-16.
15. Lee J, Lee SC, Acharya G, Chang C, Park K (2003). Hydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic property. Pharm Res, 20, 1022-30.
16. Lerner BH (2001). Breast Cancer Wars. Oxford University Press. New York.
17. Liechty WB, Peppas NA (2012). Expert opinion: Responsive polymer nanoparticles in cancer therapy. Eur J Pharm Biopharm, 80, 241-6.
18. Ludenberg BB (1997). A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol). J Pharm Pharmacol, 49, 16-21.
19. Marshall CJ (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signalregulated kinase activation. Cell, 80, 179-85.
20. Mashinchian O, Salehi R, Dehghan G, et al (2010). Novel thermosensitivepoly (N-isopropylacrylamide-covinylpyrrolidone-co-methacrylic acid) nanosystems for delivery of natural products. Inter J Drug Del, 2, 278-86.
21. Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-63.
22. Petros RA, DeSimone JM (2010). Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov, 9, 615-27.
23. Rfsler A, Vandermeulen GM, Klok HA (2001). Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev, 53, 95-108.
24. Rosler A, Vandermeulen GW, Klok HA (2001). Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Del Rev, 53, 95-108.
25. Sharma A, Straubinger RM (1994). Novel taxol formulations: preparation and characterization of Taxol containing liposomes. Pharm Res, 11, 889-96.
26. Shroff K, Kokkoli E (2012). PEGylated liposomal doxorubicin targeted to α5Î21-expressing MDA-MB-231 breast cancer cells. Langmuir, 28, 4729-36.
27. Surapaneni MS, Das SK, Das NG (2012). Designing paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges. ISRN Pharmaco, 2012, 623139.
28. Tabar L, Dean PB (2004). Mammography and breast cancer: the new era. Int J Gynaecol Obstet, 82, 319-26.
29. Trubetskoy VS (1999). Polymeric micelles as carriers of diagnostic agents. Adv Drug Deliv Rev, 37, 81-8.
30. Verderio P, Bonetti P, Colombo M, Pandolfi L, Prosperi D (2013). Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells. Biomacromole, 14, 672-82.
31. Verma AK, Chanchal A, Maitra A (2010). Co-polymeric hydrophilic nanospheres for drug delivery: Release kinetics and cellular uptakes. Ind J Exp Bio, 48, 1043-52.
32. Wang M, Thanou M (2010). Targeting nanoparticles to cancer. Pharmacol Res, 62, 90-9.
33. Wang YM, Sato H, Adachi I, Hirikoshi I (1996). Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent. Taxol Chem Pharm Bull, 44, 1935-40.
34. Ward MA, Georgiou TK (2011). Thermoresponsive polymers for biomedical applications. Polymers, 3, 1215-42.
35. Yang D, Van S, Jiang X, Yu L (2011). Novel free paclitaxel-loaded poly(L-y-glutamylglutamine)-paclitaxel nanoparticles. Int J Nanomed, 6, 85-91.